Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects

Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes

(2011) Helio S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid

(2011) Keith A. Rodvold et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and Safety of CXA-101, a New Antipseudomonal Cephalosporin, in Healthy Adult Male and Female Subjects Receiving Single- and Multiple-Dose Intravenous Infusions

(2010) Y. Ge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!

(2010) Paul G. Ambrose et al.   CLINICAL INFECTIOUS DISEASES

Three Decades of  -Lactamase Inhibitors

(2010) S. M. Drawz et al.   CLINICAL MICROBIOLOGY REVIEWS

Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia*

(2009) Emmanuel Boselli et al.   CRITICAL CARE MEDICINE

Update on the treatment of Pseudomonas aeruginosa pneumonia

(2009) A. A. El Solh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology of Healthcare-Associated Pneumonia (HCAP)

(2009) Marya Zilberberg et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE